Pub. Date : 2019
PMID : 30307354
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | CASE PRESENTATION: Here we present a KRAS/NRAS/BRAF wild-type mCRC patient who has been previously treated with FOLFIRI (fluorouracil, leucovorin, and irinotecan), XELOX (capecitabine and oxaliplatin), cetuximab and bevacizumab, and then received the next generation sequencing (NGS) and whose metastatic subcutaneous nodule was resected to generate patient-derived xenograft (PDX) models. | Leucovorin | B-Raf proto-oncogene, serine/threonine kinase | Homo sapiens |